InvestSMART

Little Green Pharma Ltd (ASX:LGP)

ALERT: Price-sensitive ASX Announcement for LGP
Current share price for LGP : $0.067 -0.033 (-33%)+
Announcement
Release
21 May 2026 9:40AM
Price at Release
$0.100
Full Release
download
Summary
The 2026 Annual Report and Appendix 4E for Little Green Pharma Ltd details the company's financial performance for the fiscal year ending 31 March 2026. The company reported a loss of $1.408 million after income tax, a decrease from the previous year's profit of $3.324 million. Total comprehensive loss for the year amounted to $3.204 million. Despite the financial loss, the company maintained a strong asset base with total assets of $93.755 million, slightly down from the previous year. Revenue from sales increased to $42.491 million, reflecting the company's growing market presence. Key management personnel remuneration details and share-based payments were also highlighted, with several Directors receiving substantial equity-based compensation. The report notes no significant events occurred after the reporting period except for a potential merger with Cannatrek Ltd, which awaits shareholder approval.
Key Points
  • Loss after income tax benefit of $1.408 million
  • Total comprehensive loss of $3.204 million for the year
  • Total assets reported at $93.755 million
  • Revenue increased to $42.491 million
  • Key management personnel received equity-based compensation
  • Potential merger with Cannatrek Ltd pending approval
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.